European Journal of Internal Medicine
Volume 19, Issue 7 , Pages 520-526 , November 2008

Waist circumference alone predicts insulin resistance as good as the metabolic syndrome in elderly women

  • Göran Nilsson

      Affiliations

    • Department of Medicine, Västerås, Stockholm, Sweden
    • Department of Clinical Research, Uppsala University, Stockholm, Sweden
    • ,
  • Pär Hedberg

      Affiliations

    • Department of Physiology, Västerås, Stockholm, Sweden
    • ,
  • Tommy Jonason

      Affiliations

    • Department of Physiology, Västerås, Stockholm, Sweden
    • ,
  • Ingemar Lönnberg

      Affiliations

    • Department of Medicine, Västerås, Stockholm, Sweden
    • ,
  • Åke Tenerz

      Affiliations

    • Department of Medicine, Västerås, Stockholm, Sweden
    • ,
  • Rosanne Forberg

      Affiliations

    • Clinical Chemistry Central Hospital, Västerås, Stockholm, Sweden
    • ,
  • John Öhrvik

      Affiliations

    • Department of Clinical Research, Uppsala University, Stockholm, Sweden
    • Department of Medicine, Karolinska Institutet, Stockholm, Sweden
    • Corresponding Author InformationCorresponding author. Department of Medicine, Cardiology Research Unit, Karolinska Institutet, SE-17176 Stockholm, Sweden. Tel.: +46 70 666 08 08; fax: +46 8 34 49 64.

Received 13 June 2007 ,Revised 17 October 2007 ,Accepted 20 January 2008.

References 

  1. Haffner SM, Miettinen H. Insulin resistance implications for type II diabetes mellitus and coronary heart disease. Am J Med. 1997;103(2):152–162
  2. Howard G, O'Leary DH, Zaccaro D, Haffner S, Rewers M, Hamman R, et al. Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation. 1996;93(10):1809–1817
  3. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2005;28(9):2289–2304
  4. Rewers M, Zaccaro D, D'Agostino R, Haffner S, Saad M, Selby J, et al. Insulin sensitivity, insulinemia, and coronary artery disease: the Insulin Resistance Atherosclerosis Study. Diabetes Care. 2004;27(3):781–787
  5. NCEP . Third report of the National Cholesterol Education Program (NCEP). NIH Publ. 2001;No 01-3670
  6. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome—a new worldwide definition. Lancet. 2005;366(9491):1059–1062
  7. Lebovitz HE, Banerji MA. Point: visceral adiposity is causally related to insulin resistance. Diabetes Care. 2005;28(9):2322–2325
  8. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237(3):E214–E223
  9. Wallace TM, Matthews DR. The assessment of insulin resistance in man. Diabet Med. 2002;19(7):527–534
  10. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–419
  11. Bonora E, Targher G, Alberiche M, Bonadonna R, Saggiani F, Zenere M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000;23(1):57–63
  12. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med. 1999;16(5):442–443
  13. Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care. 2003;26(1):61–69
  14. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502
  15. Lean ME, Han TS, Deurenberg P. Predicting body composition by densitometry from simple anthropometric measurements. Am J Clin Nutr. 1996;63(1):4–14
  16. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Jama. 2001;285(19):2486–2497
  17. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, et al. European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prev Rehabil. 2003;10(4):S1–S10
  18. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2004;27(Suppl 1):S5–S10
  19. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539–553
  20. Altman DG. In: Practical Statistics for Medical Research. Comparing groups — categorical data. Chapman &Hall; 1999;p. 267
  21. Altman DG. Diagnostic tests. In:  Altman DG,  Machin D,  Trevor NB,  Gardner M editor. Statistics with confidence. Second ed: BMJ books. 2000;p. 105–119
  22. Ciampi A, Zhang F. A new approach to training back-propagation artificial neural networks: empirical evaluation on ten data sets from clinical studies. Stat Med. 2002;21(9):1309–1330
  23. Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Heine R, Wareham NJ. Are insulin resistance, impaired fasting glucose and impaired glucose tolerance all equally strongly related to age?. Diabet Med. 2005;22(11):1476–1481
  24. Ilanne-Parikka P, Eriksson JG, Lindstrom J, Hämäläinen H, Keinänen-Kiukaanniemi S, Laakso M, et al. Prevalence of the metabolic syndrome and its components: findings from a Finnish general population sample and the Diabetes Prevention Study cohort. Diabetes Care. 2004;27(9):2135–2140
  25. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among u.s. Adults. Diabetes Care. 2004;27(10):2444–2449
  26. Banerji MA, Faridi N, Atluri R, Chaiken RL, Lebovitz HE. Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men. J Clin Endocrinol Metab. 1999;84(1):137–144
  27. Weltman A, Despres JP, Clasey JL, Weltman JY, Wideman L, Kanaley J, et al. Impact of abdominal visceral fat, growth hormone, fitness, and insulin on lipids and lipoproteins in older adults. Metabolism. 2003;52(1):73–80
  28. Seidell JC, Perusse L, Despres JP, Bouchard C. Waist and hip circumferences have independent and opposite effects on cardiovascular disease risk factors: the Quebec Family Study. Am J Clin Nutr. 2001;74(3):315–321
  29. Wang J, Thornton JC, Bari S, Williamson B, Gallagher D, Heymsfield SB, et al. Comparisons of waist circumferences measured at 4 sites. Am J Clin Nutr. 2003;77(2):379–384
  30. Wahrenberg H, Hertel K, Leijonhufvud BM, Persson LG, Toft E, Arner P. Use of waist circumference to predict insulin resistance: retrospective study. Bmj. 2005;330(7504):1363–1364
  31. Ascaso JF, Romero P, Real JT, Lorente RI, Martinez-Valls J, Carmena R. Abdominal obesity, insulin resistance, and metabolic syndrome in a southern European population. Eur J Intern Med. 2003;14(2):101–106
  32. Schreiner PJ, Terry JG, Evans GW, Hinson WH, Crouse JR, Heiss G. Sex-specific associations of magnetic resonance imaging-derived intra-abdominal and subcutaneous fat areas with conventional anthropometric indices. The Atherosclerosis Risk in Communities Study. Am J Epidemiol. 1996;144(4):335–345

PII: S0953-6205(08)00055-1

doi: 10.1016/j.ejim.2008.01.018

European Journal of Internal Medicine
Volume 19, Issue 7 , Pages 520-526 , November 2008

Article Tools

* Image Usage & Resolution